Kun Huang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Interstitial Lung Disease

Breast Cancer Cells

African American

Prognostic Factors

Top Venues

Journal of scleroderma and related disorders

Rheumatology (Oxford, England)

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Julia Tan, Evelyne Bonnardeaux, Jan P Dutz, Kamran Shojania, Fergus To, Anthony Obrzut, J Aviña-Zubieta, Kun Huang
Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients. Rheumatology (Oxford, England) (2023)
Kun Huang, Rohit Aggarwal
Antisynthetase syndrome: A distinct disease spectrum. Journal of scleroderma and related disorders 5 (3) (2020)
Kun Huang, Ophir Vinik, Kamran Shojania, James Hok Shun Yeung, Rachel Shupak, Michael Nimmo, Juan Antonio Aviña-Zubieta
Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review. Rheumatology international 39 (11) (2019)